7-hydroxystaurosporine has been researched along with aphidicolin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunch, RT; Eastman, A | 1 |
Feijoo, C; Gilbert, DM; Hall-Jackson, C; Jenkins, D; Leitch, J; Smythe, C; Wu, R | 1 |
Gillespie, DA; Rainey, MD; Zachos, G | 1 |
Aladjem, MI; Aune, GJ; Bonner, WM; Furuta, T; Hayward, RL; Kohn, KW; Meng, LH; Pommier, Y; Takemura, H | 1 |
Bonner, WM; D'Ambrosio, E; Kumari, D; Nakamura, AJ; Somma, V; Usdin, K | 1 |
5 other study(ies) available for 7-hydroxystaurosporine and aphidicolin
Article | Year |
---|---|
7-Hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; Aphidicolin; CDC2 Protein Kinase; Cell Fractionation; CHO Cells; Cisplatin; Cricetinae; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA Fragmentation; Enzyme Inhibitors; G2 Phase; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; S Phase; Staurosporine; Tumor Suppressor Protein p53 | 1997 |
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing.
Topics: Alkaloids; Animals; Aphidicolin; Ataxia Telangiectasia; Caffeine; Cell Fractionation; Cell Line; Cell Separation; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Replication; Enzyme Inhibitors; Flow Cytometry; Humans; Hydroxyurea; Immunoblotting; Microscopy, Fluorescence; Nucleic Acid Synthesis Inhibitors; Phosphodiesterase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Radiation, Ionizing; Replication Origin; S Phase; Staurosporine | 2001 |
Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures.
Topics: Animals; Antineoplastic Agents; Aphidicolin; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Chickens; DNA Replication; Gene Targeting; Mitosis; Nocodazole; Nucleic Acid Conformation; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Staurosporine | 2005 |
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine.
Topics: Aphidicolin; Apoptosis; Chromosome Breakage; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Damage; DNA Repair; DNA Replication; DNA Topoisomerases, Type I; HCT116 Cells; Histones; Humans; In Situ Nick-End Labeling; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; S Phase; Staurosporine; Tumor Suppressor Protein p53 | 2006 |
The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome.
Topics: Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Chromosome Breakage; Chromosome Fragile Sites; Chromosome Fragility; DNA Damage; DNA Repair; DNA-Binding Proteins; Floxuridine; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Knockdown Techniques; Histones; Humans; Male; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrones; Staurosporine; Tumor Suppressor Proteins | 2009 |